The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature

BACKGROUND: Colorectal cancer is the third most common and the fourth most lethal cancer in the world. In the majority of cases, patients are diagnosed at an advanced stage or even metastatic, thus explaining the high mortality. The standard treatment for patients with locally advanced non-metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauvin, Anaïs, Wang, Chang-Shu, Geha, Sameh, Garde-Granger, Perrine, Mathieu, Alex-Ane, Lacasse, Vincent, Boisvert, François-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898006/
https://www.ncbi.nlm.nih.gov/pubmed/29681787
http://dx.doi.org/10.1186/s12014-018-9192-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898006/
https://www.ncbi.nlm.nih.gov/pubmed/29681787
http://dx.doi.org/10.1186/s12014-018-9192-2

Ejemplares similares